ID   MK14_HUMAN              Reviewed;         360 AA.
AC   Q16539-2;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   12-OCT-2022, entry version 251.
DE   RecName: Full=Isoform CSBP1 of Mitogen-activated protein kinase 14 {ECO:0000305};
DE            Short=MAP kinase 14;
DE            Short=MAPK 14;
DE            EC=2.7.11.24 {ECO:0000269|PubMed:11010976, ECO:0000269|PubMed:15284239, ECO:0000269|PubMed:7493921};
DE   AltName: Full=Cytokine suppressive anti-inflammatory drug-binding protein;
DE            Short=CSAID-binding protein;
DE            Short=CSBP;
DE   AltName: Full=MAP kinase MXI2;
DE   AltName: Full=MAX-interacting protein 2;
DE   AltName: Full=Mitogen-activated protein kinase p38 alpha;
DE            Short=MAP kinase p38 alpha;
DE   AltName: Full=Stress-activated protein kinase 2a;
DE            Short=SAPK2a;
GN   Name=MAPK14 {ECO:0000312|HGNC:HGNC:6876};
GN   Synonyms=CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS CSBP1 AND CSBP2), AND PARTIAL PROTEIN
RP   SEQUENCE.
RC   TISSUE=Peripheral blood;
RX   PubMed=7997261; DOI=10.1038/372739a0;
RA   Lee J.C., Laydon J.T., McDonnell P.C., Gallagher T.F., Kumar S., Green D.,
RA   McNulty D., Blumenthal M.J., Heys R.J., Landvatter S.W., Strickler J.E.,
RA   McLaughlin M.M., Siemens I.R., Fisher S.M., Livi G.P., White J.R.,
RA   Adams J.L., Young P.R.;
RT   "A protein kinase involved in the regulation of inflammatory cytokine
RT   biosynthesis.";
RL   Nature 372:739-746(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM CSBP2).
RC   TISSUE=Liver;
RX   PubMed=7696354; DOI=10.1016/0167-4889(95)00002-a;
RA   Han J., Richter B., Li Z., Kravchenko V.V., Ulevitch R.J.;
RT   "Molecular cloning of human p38 MAP kinase.";
RL   Biochim. Biophys. Acta 1265:224-227(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM MXI2).
RX   PubMed=7479834; DOI=10.1073/pnas.92.23.10531;
RA   Zervos A.S., Faccio L., Gatto J.P., Kyriakis J.M., Brent R.;
RT   "Mxi2, a mitogen-activated protein kinase that recognizes and
RT   phosphorylates Max protein.";
RL   Proc. Natl. Acad. Sci. U.S.A. 92:10531-10534(1995).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM CSBP2).
RC   TISSUE=B-cell;
RX   PubMed=10727080; DOI=10.3109/10425179909033952;
RA   Herbison C.E., Sayer D.C., Bellgard M., Allcock R.J.N., Christiansen F.T.,
RA   Price P.;
RT   "Structure and polymorphism of two stress-activated protein kinase genes
RT   centromeric of the MHC: SAPK2a and SAPK4.";
RL   DNA Seq. 10:229-243(1999).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM EXIP), AND ACTIVITY REGULATION.
RC   TISSUE=Renal cell carcinoma;
RX   PubMed=11866441; DOI=10.1006/bbrc.2002.6529;
RA   Sudo T., Yagasaki Y., Hama H., Watanabe N., Osada H.;
RT   "Exip, a new alternative splicing variant of p38 alpha, can induce an
RT   earlier onset of apoptosis in HeLa cells.";
RL   Biochem. Biophys. Res. Commun. 291:838-843(2002).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 5).
RX   PubMed=19906316; DOI=10.1186/1471-2164-10-518;
RA   Wang P., Yu P., Gao P., Shi T., Ma D.;
RT   "Discovery of novel human transcript variants by analysis of intronic
RT   single-block EST with polyadenylation site.";
RL   BMC Genomics 10:518-518(2009).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM CSBP2).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM CSBP2).
RA   Halleck A., Ebert L., Mkoundinya M., Schick M., Eisenstein S., Neubert P.,
RA   Kstrang K., Schatten R., Shen B., Henze S., Mar W., Korn B., Zuo D., Hu Y.,
RA   LaBaer J.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NHLBI resequencing and genotyping service (RS&G);
RL   Submitted (DEC-2007) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R.,
RA   Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D.,
RA   Andrews T.D., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H.,
RA   Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E.,
RA   Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J.,
RA   French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J.,
RA   Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C.,
RA   Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A.,
RA   Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R.,
RA   Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M.,
RA   Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K.,
RA   Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R.,
RA   Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A.,
RA   Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L.,
RA   Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y.,
RA   Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E.,
RA   Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A.,
RA   Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W.,
RA   Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M.,
RA   West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J.,
RA   Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M.,
RA   Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I.,
RA   Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [13]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM CSBP2).
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [14]
RP   PROTEIN SEQUENCE OF 2-10.
RC   TISSUE=Platelet;
RX   PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A., Thomas G.R.,
RA   Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass spectrometric
RT   identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [15]
RP   PROTEIN SEQUENCE OF 174-186.
RX   PubMed=7923354; DOI=10.1016/0092-8674(94)90278-x;
RA   Freshney N.W., Rawlinson L., Guesdon F., Jones E., Cowley S., Hsuan J.,
RA   Saklatvala J.;
RT   "Interleukin-1 activates a novel protein kinase cascade that results in the
RT   phosphorylation of Hsp27.";
RL   Cell 78:1039-1049(1994).
RN   [16]
RP   PHOSPHORYLATION AT THR-180 AND TYR-182, ACTIVITY REGULATION, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=7535770; DOI=10.1074/jbc.270.13.7420;
RA   Raingeaud J., Gupta S., Rogers J.S., Dickens M., Han J., Ulevitch R.J.,
RA   Davis R.J.;
RT   "Pro-inflammatory cytokines and environmental stress cause p38 mitogen-
RT   activated protein kinase activation by dual phosphorylation on tyrosine and
RT   threonine.";
RL   J. Biol. Chem. 270:7420-7426(1995).
RN   [17]
RP   MUTAGENESIS OF ALA-34; LYS-53; ASP-168; THR-175; THR-180 AND TYR-182, AND
RP   CATALYTIC ACTIVITY.
RX   PubMed=7493921; DOI=10.1074/jbc.270.49.29043;
RA   Kumar S., McLaughlin M.M., McDonnell P.C., Lee J.C., Livi G.P., Young P.R.;
RT   "Human mitogen-activated protein kinase CSBP1, but not CSBP2, complements a
RT   hog1 deletion in yeast.";
RL   J. Biol. Chem. 270:29043-29046(1995).
RN   [18]
RP   PHOSPHORYLATION BY MAP2K3/MKK3 AND MAP2K6/MKK6, AND ACTIVITY REGULATION.
RX   PubMed=8622669; DOI=10.1128/mcb.16.3.1247;
RA   Raingeaud J., Whitmarsh A.J., Barrett T., Derijard B., Davis R.J.;
RT   "MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-
RT   activated protein kinase signal transduction pathway.";
RL   Mol. Cell. Biol. 16:1247-1255(1996).
RN   [19]
RP   FUNCTION IN ACTIVATION OF RPS6KA5/MSK1.
RX   PubMed=9687510; DOI=10.1093/emboj/17.15.4426;
RA   Deak M., Clifton A.D., Lucocq J.M., Alessi D.R.;
RT   "Mitogen- and stress-activated protein kinase-1 (MSK1) is directly
RT   activated by MAPK and SAPK2/p38, and may mediate activation of CREB.";
RL   EMBO J. 17:4426-4441(1998).
RN   [20]
RP   FUNCTION IN PHOSPHORYLATION OF ATF2; ELK1 AND MBP, AND ACTIVITY REGULATION.
RX   PubMed=9430721; DOI=10.1074/jbc.273.3.1741;
RA   Enslen H., Raingeaud J., Davis R.J.;
RT   "Selective activation of p38 mitogen-activated protein (MAP) kinase
RT   isoforms by the MAP kinase kinases MKK3 and MKK6.";
RL   J. Biol. Chem. 273:1741-1748(1998).
RN   [21]
RP   INTERACTION WITH RPS6KA4, FUNCTION IN PHOSPHORYLATION OF RPS6KA4, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=9792677; DOI=10.1074/jbc.273.45.29661;
RA   Pierrat B., Correia J.D.S., Mary J.L., Tomas-Zuber M., Lesslauer W.;
RT   "RSK-B, a novel ribosomal S6 kinase family member, is a CREB kinase under
RT   dominant control of p38alpha mitogen-activated protein kinase
RT   (p38alphaMAPK).";
RL   J. Biol. Chem. 273:29661-29671(1998).
RN   [22]
RP   INTERACTION WITH DUSP10, AND ACTIVITY REGULATION.
RX   PubMed=10391943; DOI=10.1074/jbc.274.28.19949;
RA   Tanoue T., Moriguchi T., Nishida E.;
RT   "Molecular cloning and characterization of a novel dual specificity
RT   phosphatase, MKP-5.";
RL   J. Biol. Chem. 274:19949-19956(1999).
RN   [23]
RP   FUNCTION IN PHOSPHORYLATION OF MEF2A.
RX   PubMed=9858528; DOI=10.1128/mcb.19.1.21;
RA   Zhao M., New L., Kravchenko V.V., Kato Y., Gram H., di Padova F.,
RA   Olson E.N., Ulevitch R.J., Han J.-D.;
RT   "Regulation of the MEF2 family of transcription factors by p38.";
RL   Mol. Cell. Biol. 19:21-30(1999).
RN   [24]
RP   FUNCTION IN PHOSPHORYLATION OF MEF2A AND MEF2C.
RX   PubMed=10330143; DOI=10.1128/mcb.19.6.4028;
RA   Yang S.-H., Galanis A., Sharrocks A.D.;
RT   "Targeting of p38 mitogen-activated protein kinases to MEF2 transcription
RT   factors.";
RL   Mol. Cell. Biol. 19:4028-4038(1999).
RN   [25]
RP   FUNCTION.
RC   TISSUE=Hepatoma;
RX   PubMed=10943842; DOI=10.1016/s0092-8674(00)00027-1;
RA   Tamura K., Sudo T., Senftleben U., Dadak A.M., Johnson R., Karin M.;
RT   "Requirement for p38alpha in erythropoietin expression: a role for stress
RT   kinases in erythropoiesis.";
RL   Cell 102:221-231(2000).
RN   [26]
RP   FUNCTION (ISOFORM MXI2), COFACTOR, AND ACTIVITY REGULATION.
RX   PubMed=10838079; DOI=10.1016/s0014-5793(00)01598-2;
RA   Sanz V., Arozarena I., Crespo P.;
RT   "Distinct carboxy-termini confer divergent characteristics to the mitogen-
RT   activated protein kinase p38alpha and its splice isoform Mxi2.";
RL   FEBS Lett. 474:169-174(2000).
RN   [27]
RP   INTERACTION WITH CSNK2A1 AND CSNK2B, AND FUNCTION IN ACTIVATION OF CASEIN
RP   KINASE II.
RX   PubMed=10747897; DOI=10.1074/jbc.m000312200;
RA   Sayed M., Kim S.O., Salh B.S., Issinger O.G., Pelech S.L.;
RT   "Stress-induced activation of protein kinase CK2 by direct interaction with
RT   p38 mitogen-activated protein kinase.";
RL   J. Biol. Chem. 275:16569-16573(2000).
RN   [28]
RP   INTERACTION WITH MA2PK6/MKK6, PHOSPHORYLATION BY MAP2K6/MKK6,
RP   AUTOPHOSPHORYLATION, MUTAGENESIS OF LYS-54, AND CATALYTIC ACTIVITY.
RX   PubMed=11010976; DOI=10.1074/jbc.m007835200;
RA   Alonso G., Ambrosino C., Jones M., Nebreda A.R.;
RT   "Differential activation of p38 mitogen-activated protein kinase isoforms
RT   depending on signal strength.";
RL   J. Biol. Chem. 275:40641-40648(2000).
RN   [29]
RP   INTERACTION WITH DUSP1, AND ACTIVITY REGULATION.
RX   PubMed=11278799; DOI=10.1074/jbc.m010966200;
RA   Slack D.N., Seternes O.M., Gabrielsen M., Keyse S.M.;
RT   "Distinct binding determinants for ERK2/p38alpha and JNK map kinases
RT   mediate catalytic activation and substrate selectivity of map kinase
RT   phosphatase-1.";
RL   J. Biol. Chem. 276:16491-16500(2001).
RN   [30]
RP   INTERACTION WITH DUSP16, AND ACTIVITY REGULATION.
RX   PubMed=11359773; DOI=10.1074/jbc.m101981200;
RA   Tanoue T., Yamamoto T., Maeda R., Nishida E.;
RT   "A Novel MAPK phosphatase MKP-7 acts preferentially on JNK/SAPK and p38
RT   alpha and beta MAPKs.";
RL   J. Biol. Chem. 276:26629-26639(2001).
RN   [31]
RP   FUNCTION AS MKNK2 KINASE.
RX   PubMed=11154262; DOI=10.1128/mcb.21.3.743-754.2001;
RA   Scheper G.C., Morrice N.A., Kleijn M., Proud C.G.;
RT   "The mitogen-activated protein kinase signal-integrating kinase Mnk2 is a
RT   eukaryotic initiation factor 4E kinase with high levels of basal activity
RT   in mammalian cells.";
RL   Mol. Cell. Biol. 21:743-754(2001).
RN   [32]
RP   INTERACTION WITH CDC25B AND CDC25C, AND FUNCTION IN PHOSPHORYLATION OF
RP   CDC25B AND CDC25C.
RX   PubMed=11333986; DOI=10.1038/35075107;
RA   Bulavin D.V., Higashimoto Y., Popoff I.J., Gaarde W.A., Basrur V.,
RA   Potapova O., Appella E., Fornace A.J. Jr.;
RT   "Initiation of a G2/M checkpoint after ultraviolet radiation requires p38
RT   kinase.";
RL   Nature 411:102-107(2001).
RN   [33]
RP   INTERACTION WITH TAB1, AUTOPHOSPHORYLATION, ACTIVITY REGULATION, AND
RP   CATALYTIC ACTIVITY.
RX   PubMed=11847341; DOI=10.1126/science.1067289;
RA   Ge B., Gram H., Di Padova F., Huang B., New L., Ulevitch R.J., Luo Y.,
RA   Han J.;
RT   "MAPKK-independent activation of p38alpha mediated by TAB1-dependent
RT   autophosphorylation of p38alpha.";
RL   Science 295:1291-1294(2002).
RN   [34]
RP   MUTAGENESIS OF TYR-69; ASP-176; ASP-177; ALA-320; PHE-327 AND TRP-337.
RX   PubMed=15284239; DOI=10.1074/jbc.m404595200;
RA   Diskin R., Askari N., Capone R., Engelberg D., Livnah O.;
RT   "Active mutants of the human p38alpha mitogen-activated protein kinase.";
RL   J. Biol. Chem. 279:47040-47049(2004).
RN   [35]
RP   FUNCTION IN PHOSPHORYLATION OF S100A9.
RX   PubMed=15905572; DOI=10.4049/jimmunol.174.11.7257;
RA   Lominadze G., Rane M.J., Merchant M., Cai J., Ward R.A., McLeish K.R.;
RT   "Myeloid-related protein-14 is a p38 MAPK substrate in human neutrophils.";
RL   J. Immunol. 174:7257-7267(2005).
RN   [36]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=15592455; DOI=10.1038/nbt1046;
RA   Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,
RA   Zha X.-M., Polakiewicz R.D., Comb M.J.;
RT   "Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.";
RL   Nat. Biotechnol. 23:94-101(2005).
RN   [37]
RP   PHOSPHORYLATION AT TYR-323, AND ACTIVITY REGULATION.
RX   PubMed=15735648; DOI=10.1038/ni1177;
RA   Salvador J.M., Mittelstadt P.R., Guszczynski T., Copeland T.D.,
RA   Yamaguchi H., Appella E., Fornace A.J. Jr., Ashwell J.D.;
RT   "Alternative p38 activation pathway mediated by T cell receptor-proximal
RT   tyrosine kinases.";
RL   Nat. Immunol. 6:390-395(2005).
RN   [38]
RP   INTERACTION WITH TAB1, AUTOPHOSPHORYLATION, AND ACTIVITY REGULATION.
RX   PubMed=15735649; DOI=10.1038/ni1176;
RA   Salvador J.M., Mittelstadt P.R., Belova G.I., Fornace A.J. Jr.,
RA   Ashwell J.D.;
RT   "The autoimmune suppressor Gadd45alpha inhibits the T cell alternative p38
RT   activation pathway.";
RL   Nat. Immunol. 6:396-402(2005).
RN   [39]
RP   INTERACTION WITH SUPT20H.
RX   PubMed=16751104; DOI=10.1016/j.cell.2006.03.048;
RA   Zohn I.E., Li Y., Skolnik E.Y., Anderson K.V., Han J., Niswander L.;
RT   "p38 and a p38-interacting protein are critical for downregulation of E-
RT   cadherin during mouse gastrulation.";
RL   Cell 125:957-969(2006).
RN   [40]
RP   FUNCTION IN STRESS-INDUCED INTERNALIZATION OF EGFR.
RX   PubMed=16932740; DOI=10.1038/sj.emboj.7601297;
RA   Zwang Y., Yarden Y.;
RT   "p38 MAP kinase mediates stress-induced internalization of EGFR:
RT   implications for cancer chemotherapy.";
RL   EMBO J. 25:4195-4206(2006).
RN   [41]
RP   FUNCTION IN PHOSPHORYLATION OF SIAH2, AND ACTIVITY REGULATION.
RX   PubMed=17003045; DOI=10.1074/jbc.m606568200;
RA   Khurana A., Nakayama K., Williams S., Davis R.J., Mustelin T., Ronai Z.;
RT   "Regulation of the ring finger E3 ligase Siah2 by p38 MAPK.";
RL   J. Biol. Chem. 281:35316-35326(2006).
RN   [42]
RP   INTERACTION WITH NP60.
RX   PubMed=16352664; DOI=10.1242/jcs.02699;
RA   Fu J., Yang Z., Wei J., Han J., Gu J.;
RT   "Nuclear protein NP60 regulates p38 MAPK activity.";
RL   J. Cell Sci. 119:115-123(2006).
RN   [43]
RP   FUNCTION, PHOSPHORYLATION, SUBCELLULAR LOCATION, AND UBIQUITINATION.
RX   PubMed=17724032; DOI=10.1074/jbc.m703857200;
RA   Qi X., Pohl N.M., Loesch M., Hou S., Li R., Qin J.Z., Cuenda A., Chen G.;
RT   "p38alpha antagonizes p38gamma activity through c-Jun-dependent ubiquitin-
RT   proteasome pathways in regulating Ras transformation and stress response.";
RL   J. Biol. Chem. 282:31398-31408(2007).
RN   [44]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-263, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III, Hurov K.E.,
RA   Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., Shiloh Y.,
RA   Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [45]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [46]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-16, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [47]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-180 AND TYR-182, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [48]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.m800588-mcp200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [49]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-180 AND TYR-182, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [50]
RP   FUNCTION IN INHIBITION OF AUTOPHAGY.
RX   PubMed=19893488; DOI=10.1038/emboj.2009.321;
RA   Webber J.L., Tooze S.A.;
RT   "Coordinated regulation of autophagy by p38alpha MAPK through mAtg9 and
RT   p38IP.";
RL   EMBO J. 29:27-40(2010).
RN   [51]
RP   FUNCTION IN PHOSPHORYLATION OF TIAR.
RX   PubMed=20932473; DOI=10.1016/j.molcel.2010.09.018;
RA   Reinhardt H.C., Hasskamp P., Schmedding I., Morandell S., van Vugt M.A.,
RA   Wang X., Linding R., Ong S.E., Weaver D., Carr S.A., Yaffe M.B.;
RT   "DNA damage activates a spatially distinct late cytoplasmic cell-cycle
RT   checkpoint network controlled by MK2-mediated RNA stabilization.";
RL   Mol. Cell 40:34-49(2010).
RN   [52]
RP   INTERACTION WITH ADAM17, AND FUNCTION IN PHOSPHORYLATION OF ADAM17.
RX   PubMed=20188673; DOI=10.1016/j.molcel.2010.01.034;
RA   Xu P., Derynck R.;
RT   "Direct activation of TACE-mediated ectodomain shedding by p38 MAP kinase
RT   regulates EGF receptor-dependent cell proliferation.";
RL   Mol. Cell 37:551-566(2010).
RN   [53]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, PHOSPHORYLATION [LARGE SCALE
RP   ANALYSIS] AT SER-2; THR-180 AND TYR-182, CLEAVAGE OF INITIATOR METHIONINE
RP   [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [54]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [55]
RP   IDENTIFICATION IN A COMPLEX WITH AKAP13; PKN1; ZAK AND MAP2K3.
RX   PubMed=21224381; DOI=10.1074/jbc.m110.185645;
RA   Cariolato L., Cavin S., Diviani D.;
RT   "A-kinase anchoring protein (AKAP)-Lbc anchors a PKN-based signaling
RT   complex involved in alpha1-adrenergic receptor-induced p38 activation.";
RL   J. Biol. Chem. 286:7925-7937(2011).
RN   [56]
RP   FUNCTION (MICROBIAL INFECTION).
RC   TISSUE=T-cell;
RX   PubMed=21586573; DOI=10.1074/jbc.m111.234062;
RA   Peng H., Wang X., Barnes P.F., Tang H., Townsend J.C., Samten B.;
RT   "The Mycobacterium tuberculosis early secreted antigenic target of 6 kDa
RT   inhibits T cell interferon-gamma production through the p38 mitogen-
RT   activated protein kinase pathway.";
RL   J. Biol. Chem. 286:24508-24518(2011).
RN   [57]
RP   ACETYLATION AT LYS-53 AND LYS-152 BY KAT2B/PCAF AND EP300, AND
RP   DEACETYLATION BY HDAC3.
RX   PubMed=21444723; DOI=10.1128/mcb.01205-10;
RA   Pillai V.B., Sundaresan N.R., Samant S.A., Wolfgeher D., Trivedi C.M.,
RA   Gupta M.P.;
RT   "Acetylation of a conserved lysine residue in the ATP binding pocket of p38
RT   augments its kinase activity during hypertrophy of cardiomyocytes.";
RL   Mol. Cell. Biol. 31:2349-2363(2011).
RN   [58]
RP   INTERACTION WITH CDK5RAP3 AND PPM1D, AND DEPHOSPHORYLATION BY PPM1D.
RX   PubMed=21283629; DOI=10.1371/journal.pone.0016427;
RA   An H., Lu X., Liu D., Yarbrough W.G.;
RT   "LZAP inhibits p38 MAPK (p38) phosphorylation and activity by facilitating
RT   p38 association with the wild-type p53 induced phosphatase 1 (WIP1).";
RL   PLoS ONE 6:E16427-E16427(2011).
RN   [59]
RP   REVIEW ON FUNCTION.
RX   PubMed=12452429; DOI=10.1515/bc.2002.173;
RA   Shi Y., Gaestel M.;
RT   "In the cellular garden of forking paths: how p38 MAPKs signal for
RT   downstream assistance.";
RL   Biol. Chem. 383:1519-1536(2002).
RN   [60]
RP   REVIEW ON ACTIVITY REGULATION, AND REVIEW ON FUNCTION.
RX   PubMed=20626350; DOI=10.1042/bj20100323;
RA   Cuadrado A., Nebreda A.R.;
RT   "Mechanisms and functions of p38 MAPK signalling.";
RL   Biochem. J. 429:403-417(2010).
RN   [61]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2; THR-180 AND TYR-182, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [62]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [63]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [64]
RP   SUBCELLULAR LOCATION.
RX   PubMed=30878395; DOI=10.1016/j.yjmcc.2019.03.005;
RA   Li C., Li J., Xue K., Zhang J., Wang C., Zhang Q., Chen X., Gao C., Yu X.,
RA   Sun L.;
RT   "MicroRNA-143-3p promotes human cardiac fibrosis via targeting sprouty3
RT   after myocardial infarction.";
RL   J. Mol. Cell. Cardiol. 129:281-292(2019).
RN   [65]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS).
RX   PubMed=8910361; DOI=10.1074/jbc.271.44.27696;
RA   Wilson K.P., Fitzgibbon M.J., Caron P.R., Griffith J.P., Chen W.,
RA   McCaffrey P.G., Chambers S.P., Su M.S.-S.;
RT   "Crystal structure of p38 mitogen-activated protein kinase.";
RL   J. Biol. Chem. 271:27696-27700(1996).
RN   [66]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS).
RX   PubMed=9095200; DOI=10.1038/nsb0497-311;
RA   Tong L., Pav S., White D.M., Rogers S., Crane K.M., Cywin C.L., Brown M.L.,
RA   Pargellis C.A.;
RT   "A highly specific inhibitor of human p38 MAP kinase binds in the ATP
RT   pocket.";
RL   Nat. Struct. Biol. 4:311-316(1997).
RN   [67]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS).
RX   PubMed=9753691; DOI=10.1016/s0969-2126(98)00113-0;
RA   Wang Z., Canagarajah B.J., Boehm J.C., Kassisa S., Cobb M.H., Young P.R.,
RA   Abdel-Meguid S., Adams J.L., Goldsmith E.J.;
RT   "Structural basis of inhibitor selectivity in MAP kinases.";
RL   Structure 6:1117-1128(1998).
RN   [68]
RP   X-RAY CRYSTALLOGRAPHY (2.60 ANGSTROMS).
RX   PubMed=10633045; DOI=10.1021/jm990401t;
RA   Shewchuk L., Hassell A., Wisely B., Rocque W., Holmes W., Veal J.,
RA   Kuyper L.F.;
RT   "Binding mode of the 4-anilinoquinazoline class of protein kinase
RT   inhibitor: X-ray crystallographic studies of 4-anilinoquinazolines bound to
RT   cyclin-dependent kinase 2 and p38 kinase.";
RL   J. Med. Chem. 43:133-138(2000).
RN   [69]
RP   X-RAY CRYSTALLOGRAPHY (2.50 ANGSTROMS), AND ACTIVITY REGULATION.
RX   PubMed=11896401; DOI=10.1038/nsb770;
RA   Pargellis C., Tong L., Churchill L., Cirillo P.F., Gilmore T., Graham A.G.,
RA   Grob P.M., Hickey E.R., Moss N., Pav S., Regan J.;
RT   "Inhibition of p38 MAP kinase by utilizing a novel allosteric binding
RT   site.";
RL   Nat. Struct. Biol. 9:268-272(2002).
RN   [70]
RP   X-RAY CRYSTALLOGRAPHY (2.40 ANGSTROMS), AND ACTIVITY REGULATION.
RX   PubMed=12482439; DOI=10.1016/s0960-894x(02)00752-7;
RA   Stelmach J.E., Liu L., Patel S.B., Pivnichny J.V., Scapin G., Singh S.,
RA   Hop C.E., Wang Z., Strauss J.R., Cameron P.M., Nichols E.A., O'Keefe S.J.,
RA   O'Neill E.A., Schmatz D.M., Schwartz C.D., Thompson C.M., Zaller D.M.,
RA   Doherty J.B.;
RT   "Design and synthesis of potent, orally bioavailable dihydroquinazolinone
RT   inhibitors of p38 MAP kinase.";
RL   Bioorg. Med. Chem. Lett. 13:277-280(2003).
RN   [71]
RP   X-RAY CRYSTALLOGRAPHY (2.10 ANGSTROMS), AND ACTIVITY REGULATION.
RX   PubMed=14561090; DOI=10.1021/jm0301787;
RA   Trejo A., Arzeno H., Browner M., Chanda S., Cheng S., Comer D.D.,
RA   Dalrymple S.A., Dunten P., Lafargue J., Lovejoy B., Freire-Moar J., Lim J.,
RA   Mcintosh J., Miller J., Papp E., Reuter D., Roberts R., Sanpablo F.,
RA   Saunders J., Song K., Villasenor A., Warren S.D., Welch M., Weller P.,
RA   Whiteley P.E., Zeng L., Goldstein D.M.;
RT   "Design and synthesis of 4-azaindoles as inhibitors of p38 MAP kinase.";
RL   J. Med. Chem. 46:4702-4713(2003).
RN   [72] {ECO:0007744|PDB:1OUK, ECO:0007744|PDB:1OUY, ECO:0007744|PDB:1OVE}
RP   X-RAY CRYSTALLOGRAPHY (2.10 ANGSTROMS) IN COMPLEX WITH INHIBITOR.
RX   PubMed=12897767; DOI=10.1038/nsb949;
RA   Fitzgerald C.E., Patel S.B., Becker J.W., Cameron P.M., Zaller D.,
RA   Pikounis V.B., O'Keefe S.J., Scapin G.;
RT   "Structural basis for p38alpha MAP kinase quinazolinone and pyridol-
RT   pyrimidine inhibitor specificity.";
RL   Nat. Struct. Biol. 10:764-769(2003).
RN   [73]
RP   X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS), AND ACTIVITY REGULATION.
RX   PubMed=14726206; DOI=10.1016/j.bbapap.2003.09.009;
RA   Patel S.B., Cameron P.M., Frantz-Wattley B., O'Neill E., Becker J.W.,
RA   Scapin G.;
RT   "Lattice stabilization and enhanced diffraction in human p38 alpha crystals
RT   by protein engineering.";
RL   Biochim. Biophys. Acta 1696:67-73(2004).
RN   [74] {ECO:0007744|PDB:2BAJ, ECO:0007744|PDB:2BAK, ECO:0007744|PDB:2BAL, ECO:0007744|PDB:2BAQ}
RP   X-RAY CRYSTALLOGRAPHY (2.10 ANGSTROMS) OF 2-359 IN COMPLEX WITH INHIBITOR.
RX   PubMed=16342939; DOI=10.1021/bi051714v;
RA   Sullivan J.E., Holdgate G.A., Campbell D., Timms D., Gerhardt S., Breed J.,
RA   Breeze A.L., Bermingham A., Pauptit R.A., Norman R.A., Embrey K.J.,
RA   Read J., VanScyoc W.S., Ward W.H.;
RT   "Prevention of MKK6-dependent activation by binding to p38alpha MAP
RT   kinase.";
RL   Biochemistry 44:16475-16490(2005).
RN   [75]
RP   X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF 2-359, AND ACTIVITY REGULATION.
RX   PubMed=15837335; DOI=10.1016/j.bmcl.2005.02.010;
RA   Tamayo N., Liao L., Goldberg M., Powers D., Tudor Y.Y., Yu V., Wong L.M.,
RA   Henkle B., Middleton S., Syed R., Harvey T., Jang G., Hungate R.,
RA   Dominguez C.;
RT   "Design and synthesis of potent pyridazine inhibitors of p38 MAP kinase.";
RL   Bioorg. Med. Chem. Lett. 15:2409-2413(2005).
RN   [76]
RP   X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS), AND ACTIVITY REGULATION.
RX   PubMed=16169718; DOI=10.1016/j.bmcl.2005.08.038;
RA   Michelotti E.L., Moffett K.K., Nguyen D., Kelly M.J., Shetty R., Chai X.,
RA   Northrop K., Namboodiri V., Campbell B., Flynn G.A., Fujimoto T.,
RA   Hollinger F.P., Bukhtiyarova M., Springman E.B., Karpusas M.;
RT   "Two classes of p38alpha MAP kinase inhibitors having a common
RT   diphenylether core but exhibiting divergent binding modes.";
RL   Bioorg. Med. Chem. Lett. 15:5274-5279(2005).
RN   [77] {ECO:0007744|PDB:1W7H, ECO:0007744|PDB:1WBO}
RP   X-RAY CRYSTALLOGRAPHY (2.16 ANGSTROMS) OF 2-359 IN COMPLEX WITH INHIBITOR.
RX   PubMed=15658854; DOI=10.1021/jm0495778;
RA   Hartshorn M.J., Murray C.W., Cleasby A., Frederickson M., Tickle I.J.,
RA   Jhoti H.;
RT   "Fragment-based lead discovery using X-ray crystallography.";
RL   J. Med. Chem. 48:403-413(2005).
RN   [78]
RP   X-RAY CRYSTALLOGRAPHY (4.0 ANGSTROMS) OF 2-359 IN COMPLEX WITH MAPKAPK2.
RX   PubMed=17255097; DOI=10.1074/jbc.m611165200;
RA   ter Haar E., Prabhakar P., Liu X., Lepre C.;
RT   "Crystal structure of the p38 alpha-MAPKAP kinase 2 heterodimer.";
RL   J. Biol. Chem. 282:9733-9739(2007).
RN   [79]
RP   ERRATUM OF PUBMED:17255097.
RA   ter Haar E., Prabhakar P., Liu X., Lepre C.;
RL   J. Biol. Chem. 282:14684-14684(2007).
RN   [80]
RP   VARIANTS [LARGE SCALE ANALYSIS] VAL-51; ARG-322 AND GLY-343.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=CSBP2;
CC         IsoId=Q16539-1; Sequence=Displayed;
CC       Name=CSBP1;
CC         IsoId=Q16539-2; Sequence=VSP_004842;
CC       Name=Mxi2;
CC         IsoId=Q16539-3; Sequence=VSP_004844;
CC       Name=Exip; Synonyms=Exon skip;
CC         IsoId=Q16539-4; Sequence=VSP_004843, VSP_004845;
CC       Name=5;
CC         IsoId=Q16539-5; Sequence=VSP_057194;
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   CCDS; CCDS4815.1; -.
DR   RefSeq; NP_001306.1; NM_001315.2.
DR   ProteomicsDB; 60902; -.
DR   Ensembl; ENST00000229795.7; ENSP00000229795.3; ENSG00000112062.11.
DR   Proteomes; UP000005640; Chromosome 6.
PE   1: Evidence at protein level;
SQ   SEQUENCE   360 AA;  41493 MW;  062EBC3E56683D14 CRC64;
     MSQERPTFYR QELNKTIWEV PERYQNLSPV GSGAYGSVCA AFDTKTGLRV AVKKLSRPFQ
     SIIHAKRTYR ELRLLKHMKH ENVIGLLDVF TPARSLEEFN DVYLVTHLMG ADLNNIVKCQ
     KLTDDHVQFL IYQILRGLKY IHSADIIHRD LKPSNLAVNE DCELKILDFG LARHTDDEMT
     GYVATRWYRA PEIMLNWMHY NQTVDIWSVG CIMAELLTGR TLFPGTDHIN QLQQIMRLTG
     TPPAYLINRM PSHEARNYIQ SLTQMPKMNF ANVFIGANPL AVDLLEKMLV LDSDKRITAA
     QALAHAYFAQ YHDPDDEPVA DPYDQSFESR DLLIDEWKSL TYDEVISFVP PPLDQEEMES
//
